Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2013

Aug 9, 2013

30339_dirs_2013-08-09_47972748-88df-4e58-a626-0976a36967f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-08-07

Reporting Person: Hunt Jeffrey C (VP Pharma Pckg Systems)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-08-07 Common Stock M 3152.0000 $36.2900 Acquired 10780.4832 Direct
2013-08-07 Common Stock S 3152.0000 $78.4689 Disposed 7628.4832 Direct
2013-08-08 Common Stock M 5708.0000 $40.8500 Acquired 13336.4832 Direct
2013-08-08 Common Stock S 5708.0000 $78.0000 Disposed 7628.4832 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-08-07 Stock Option (Right to Buy) $36.2900 M 3152.0000 Disposed 2020-07-06 Common Stock (3152.0000) Direct
2013-08-08 Stock Option (Right to Buy) $40.8500 M 5708.0000 Disposed 2021-02-22 Common Stock (5708.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 325.6324 Indirect
Common Stock 7573.6616 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.